This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a chiral intermediate in the production of specific drugs, especially those targeting neurological disorders or acting as receptor modulators. Its structure, featuring a methoxypyridine moiety, makes it valuable in designing molecules with enhanced binding affinity and selectivity. Additionally, it is employed in the development of enantiomerically pure compounds, ensuring high efficacy and reduced side effects in therapeutic applications. Researchers also explore its potential in creating novel compounds for treating conditions like anxiety, depression, or other central nervous system-related diseases.